Articles From: Anthera Pharmaceuticals Announces Completion of Interim Analysis from Phase 3 Trial with Blisibimod for Systemic Lupus Erythematosus to AOL Expands Global Scale in Video Distribution, Discovery and Management Through Acquisition of Vidible


2015/2/10
-- CHABLIS-SC1 study passes futility analysis and will continue to completion with an enhanced endpoint -- Enrollment to be completed in 2015 with final data in Q3 2016 --
Sign-up for Anthera Pharmaceuticals Announces Completion of Interim Analysis from Phase 3 Trial with Blisibimod for Systemic Lupus Erythematosus investment picks
2014/12/30
HAYWARD, Calif.
Sign-up for Anthera Pharmaceuticals Announces Lupus Symposium During 2015 JP Morgan Healthcare Conference investment picks
2014/12/15
- Anthera to receive up to $48,000,000 plus future product margin on commercial supply - Zenyaku to reimburse Anthera for a portion of future blisibimod worldwide development costs - Zenyaku to assume full responsibility for development and associated costs in Japan and potentially other Asian territories in the future - Companies will collaborate on blisibimod development for both IgA Nephropathy ("IgAN") and Systemic Lupus Erythematosus ("Lupus") HAYWARD, Calif.
Sign-up for Anthera Pharmaceuticals Licenses Japan Rights for Blisibimod to Zenyaku Kogyo Co., Ltd. investment picks
2015/2/10
HAYWARD, Calif.
Sign-up for Anthera Pharmaceuticals Regains Compliance with Nasdaq Listing Requirements investment picks
2015/2/19
HAYWARD, Calif.
Sign-up for Anthera Pharmaceuticals to Present at Cowen & Co. Healthcare Conference investment picks
2015/2/17
Led Company through Mergers and Unprecedented Growth AKRON, Ohio , Feb.
Sign-up for Anthony J. Alexander Concludes 43 Years of Service at FirstEnergy investment picks
2015/1/22
Xylem Inc. (NYSE:XYL), a leading global water technology company dedicated to solving the world’s most challenging water issues, today announced the appointment of Anthony Milando as Senior Vice President for Continuous Improvement and Business Transformation, effective February 2, 2015.
Sign-up for Anthony Milando to join Xylem as Senior Vice President of Continuous Improvement and Business Transformation investment picks
2014/12/5
- Potential Treatment for Hospitalized Patients with Complicated Intra-Abdominal and Complicated Urinary Tract Infections - - Potential Approval to address serious or Life-threatening Infections where an Unmet Need exists in Patients for whom limited or no Treatment Options are Available - DUBLIN , Dec.
Sign-up for Anti-Infective Advisory Committee Recommends Approval Of Actavis' Ceftazidime-Avibactam investment picks
2014/12/8
Bristol-Myers Squibb Company (NYSE:BMY) and Pfizer Inc. (NYSE:PFE) today announced results of the first human study evaluating the reversal of the anticoagulant effect of Eliquis (apixaban) by 4-factor prothrombin complex concentrates (PCCs) in healthy subjects.
Sign-up for Anticoagulant Effect of Eliquis (apixaban) Reversed by Two Separate 4-Factor Prothrombin Complex Concentrates in Healthy Subjects investment picks
2015/2/4
In addition to lowering its Carbon Footprint, District Estimates Solar Power will Save $39 Million Over the Next 30 Years ANTIOCH, Calif.
Sign-up for Antioch Unified School District Scores Extra Credit with Sun Power Systems at 20 Schools investment picks
2015/2/16
(FROM THE WALL STREET JOURNAL 2/17/15) By Drew Fitzgerald Expedia Inc.'s deal to buy rival Orbitz Worldwide Inc. makes it one of the most acquisitive online travel companies in the world, but it wasn't long ago that it was warning regulators against a deal in the industry.
Sign-up for Antitrust Paradox Hangs Over Expedia investment picks
2015/2/23
By Alex MacDonald LONDON--Chilean copper producer Antofagasta PLC (ANTO.LN) Monday lowered its cash cost guidance by 10% for the current year due to more favorable input costs, particularly a weaker Chilean peso and lower oil price.
Sign-up for Antofagasta Lowers Net Cash Cost Guidance by 10% for 2015 investment picks
2015/1/12
By Eric Garcia, MarketWatch WASHINGTON (MarketWatch)--Antonio Weiss, who has been nominated by President Barack Obama for a position at the Treasury Department, asked to no longer be considered after he faced criticism from Democrats for his connections to Wall Street.
Sign-up for Antonio Weiss pulls out of running for treasury post investment picks
2015/1/30
Anworth Mortgage Asset Corporation (NYSE: ANH), a real estate investment trust (REIT), announced today tax information regarding its dividend distributions for the Company’s fiscal year ended December 31, 2014.
Sign-up for Anworth Announces 2014 Dividend Tax Information investment picks
2014/12/30
Anworth Mortgage Asset Corporation (NYSE: ANH) announced that in accordance with the terms of Anworth’s 6.25% Series B Cumulative Convertible Preferred Stock, or Series B Preferred Stock, the conversion rate of the Series B Preferred Stock will increase from 4.1519 shares of Anworth’s common stock to 4.2029 shares of its common stock effective December 31, 2014.
Sign-up for Anworth Announces Increase to Series B Preferred Stock Conversion Rate investment picks
2015/1/20
Anworth Mortgage Asset Corporation (NYSE: ANH) (the “Company”) announced today that it has priced an underwritten public offering of 300,000 shares of its 7.625% Series C Cumulative Redeemable Preferred Stock (“Series C Preferred Stock”) at a public offering price of $24.50 per share.
Sign-up for Anworth Announces Pricing of Public Offering of Its 7.625% Series C Preferred Stock investment picks
2015/1/15
Anworth Mortgage Asset Corporation (NYSE: ANH) (the “Company”) announced today that it has commenced an underwritten public offering of its new 7.625% Series C Cumulative Redeemable Preferred Stock (“Series C Preferred Stock”). The Company expects to grant the underwriters a 30-day option to purchase additional shares of Series C Preferred Stock to cover over-allotments, if any.
Sign-up for Anworth Announces Public Offering of Its New Series C Cumulative Redeemable Preferred Stock investment picks
2015/1/15
Anworth Mortgage Asset Corporation (NYSE: ANH) announced today that, in accordance with the terms of Anworth’s 8.625% Series A Cumulative Preferred Stock, or Series A Preferred Stock, the board of directors declared a Series A Preferred Stock dividend of $0.539063 per share for the first quarter of 2015.
Sign-up for Anworth Announces Series A and Series B Preferred Stock Dividends investment picks
2014/12/18
Anworth Mortgage Asset Corporation (NYSE: ANH) announced today that its Board of Directors declared a quarterly common stock dividend of $0.14 per share for the fourth quarter of 2014.
Sign-up for Anworth Declares a $0.14 Per Share Fourth Quarter 2014 Common Dividend investment picks
2015/2/11
Anworth Mortgage Asset Corporation (NYSE: ANH) (the “Company”) today reported its financial results for the fourth quarter ended December 31, 2014.
Sign-up for Anworth Reports Fourth Quarter 2014 Financial Results investment picks
2015/2/10
Anworth Mortgage Asset Corporation (NYSE: ANH) (the “Company”) announced today that it will release results for the fourth quarter of 2014 following the close of trading on the New York Stock Exchange on Wednesday, February 11, 2015.
Sign-up for Anworth Schedules Fourth Quarter 2014 Earnings Release and Conference Call investment picks
2015/2/15
By Robb M.
Sign-up for ANZ Names Mark Whelan to Succeed Philip Chronican as Australia CEO investment picks
2015/2/16
By Robb M.
Sign-up for ANZ Quarterly Profit Steady, Margins Under Pressure investment picks
2015/2/16
By Robb M.
Sign-up for ANZ Reports Steady Profit, But Margins Under Pressure investment picks
2015/2/15
MELBOURNE, Australia--Australia & New Zealand Banking Group Ltd.'s (ANZ.AU) managing director for global commercial banking has been tapped to take over as chief executive for the lender's operations at home in Australia, succeeding banking veteran Philip Chronican.
Sign-up for ANZ Taps Mark Whelan as Australia CEO investment picks
2015/2/14
AOL Inc. (AOL) today announced it has been selected by The Players’ Tribune , a first-of-its-kind digital media company founded by Derek Jeter, to be the distribution and co-production launch partner.
Sign-up for AOL Announces Strategic Partnership with The Players’ Tribune investment picks
2015/2/11
AOL Inc. (AOL) reported on Wednesday a fourth-quarter net profit that rose to $59.6 million, or 73 cents a share, from $36 million, or 43 cents a share, in the year-earlier period.
Sign-up for AOL beats profit expectations, but falls short on revenue investment picks
2015/2/11
AOL Inc. (NYSE:AOL) released fourth quarter and full year 2014 results today.
Sign-up for AOL Delivers 2nd Consecutive Year of Revenue and 3rd Year of Adjusted OIBDA Growth investment picks
2014/12/1
AOL Inc. (NYSE:AOL) today announced it has acquired Vidible Inc., the leading independent cross-screen video management and exchange platform for buyers and sellers of digital media.
Sign-up for AOL Expands Global Scale in Video Distribution, Discovery and Management Through Acquisition of Vidible investment picks
Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: Anthera Pharmaceuticals Announces Completion of Interim Analysis from Phase 3 Trial with Blisibimod for Systemic Lupus Erythematosus to AOL Expands Global Scale in Video Distribution, Discovery and Management Through Acquisition of Vidible
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent